[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

FR2878746B1 - Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins - Google Patents

Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins

Info

Publication number
FR2878746B1
FR2878746B1 FR0452838A FR0452838A FR2878746B1 FR 2878746 B1 FR2878746 B1 FR 2878746B1 FR 0452838 A FR0452838 A FR 0452838A FR 0452838 A FR0452838 A FR 0452838A FR 2878746 B1 FR2878746 B1 FR 2878746B1
Authority
FR
France
Prior art keywords
vaccines
field
pharmaceutical composition
novel pharmaceutical
novel
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR0452838A
Other languages
English (en)
Other versions
FR2878746A1 (fr
Inventor
Marinette Moreau
Nicolas Osty
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vetoquinol SA
Original Assignee
Vetoquinol SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR0452838A priority Critical patent/FR2878746B1/fr
Application filed by Vetoquinol SA filed Critical Vetoquinol SA
Priority to EP05824496A priority patent/EP1817053A1/fr
Priority to UAA200707275A priority patent/UA91203C2/ru
Priority to NZ555743A priority patent/NZ555743A/en
Priority to KR1020077015073A priority patent/KR20070106988A/ko
Priority to JP2007543883A priority patent/JP4987725B2/ja
Priority to US11/792,122 priority patent/US8158133B2/en
Priority to CA002589841A priority patent/CA2589841A1/fr
Priority to AU2005311188A priority patent/AU2005311188B2/en
Priority to BRPI0517124-5A priority patent/BRPI0517124A/pt
Priority to PCT/FR2005/002995 priority patent/WO2006059009A1/fr
Priority to EA200701201A priority patent/EA200701201A1/ru
Priority to CNA2005800475531A priority patent/CN101111262A/zh
Priority to MX2007006521A priority patent/MX2007006521A/es
Publication of FR2878746A1 publication Critical patent/FR2878746A1/fr
Application granted granted Critical
Publication of FR2878746B1 publication Critical patent/FR2878746B1/fr
Priority to IL183518A priority patent/IL183518A/en
Priority to ZA200705079A priority patent/ZA200705079B/xx
Priority to NO20073333A priority patent/NO20073333L/no
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/113—Multiple emulsions, e.g. oil-in-water-in-oil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Dispersion Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
FR0452838A 2004-12-02 2004-12-02 Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins Expired - Fee Related FR2878746B1 (fr)

Priority Applications (17)

Application Number Priority Date Filing Date Title
FR0452838A FR2878746B1 (fr) 2004-12-02 2004-12-02 Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins
CNA2005800475531A CN101111262A (zh) 2004-12-02 2005-12-01 可用于疫苗的新的药物组合物
NZ555743A NZ555743A (en) 2004-12-02 2005-12-01 Novel pharmaceutical composition useful for vaccines
KR1020077015073A KR20070106988A (ko) 2004-12-02 2005-12-01 백신용 약학적 조성물
JP2007543883A JP4987725B2 (ja) 2004-12-02 2005-12-01 ワクチンに有用な新規医薬組成物及びその調製方法
US11/792,122 US8158133B2 (en) 2004-12-02 2005-12-01 Pharmaceutical composition useful for vaccines
CA002589841A CA2589841A1 (fr) 2004-12-02 2005-12-01 Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins
AU2005311188A AU2005311188B2 (en) 2004-12-02 2005-12-01 Novel pharmaceutical composition useful for vaccines
EP05824496A EP1817053A1 (fr) 2004-12-02 2005-12-01 Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins
PCT/FR2005/002995 WO2006059009A1 (fr) 2004-12-02 2005-12-01 Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins
EA200701201A EA200701201A1 (ru) 2004-12-02 2005-12-01 Новая фармацевтическая композиция для вакцин
UAA200707275A UA91203C2 (ru) 2004-12-02 2005-12-01 Новая фармацевтическая композиция, применимая для вакцин
MX2007006521A MX2007006521A (es) 2004-12-02 2005-12-01 Nuevas composiciones farmaceuticas utiles para vacunas.
BRPI0517124-5A BRPI0517124A (pt) 2004-12-02 2005-12-01 composição farmacêutica e processo de preparação de uma composição
IL183518A IL183518A (en) 2004-12-02 2007-05-29 Pharmaceutical composition in the form of oily isotropes including at least one oil, at least one surfactant and an aqueous phase
ZA200705079A ZA200705079B (en) 2004-12-02 2007-06-12 Novel pharmaceutical composition useful for vaccines
NO20073333A NO20073333L (no) 2004-12-02 2007-06-28 Nye farmasoytiske sammensetninger for vaksiner

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0452838A FR2878746B1 (fr) 2004-12-02 2004-12-02 Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins

Publications (2)

Publication Number Publication Date
FR2878746A1 FR2878746A1 (fr) 2006-06-09
FR2878746B1 true FR2878746B1 (fr) 2007-02-23

Family

ID=34952132

Family Applications (1)

Application Number Title Priority Date Filing Date
FR0452838A Expired - Fee Related FR2878746B1 (fr) 2004-12-02 2004-12-02 Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins

Country Status (17)

Country Link
US (1) US8158133B2 (fr)
EP (1) EP1817053A1 (fr)
JP (1) JP4987725B2 (fr)
KR (1) KR20070106988A (fr)
CN (1) CN101111262A (fr)
AU (1) AU2005311188B2 (fr)
BR (1) BRPI0517124A (fr)
CA (1) CA2589841A1 (fr)
EA (1) EA200701201A1 (fr)
FR (1) FR2878746B1 (fr)
IL (1) IL183518A (fr)
MX (1) MX2007006521A (fr)
NO (1) NO20073333L (fr)
NZ (1) NZ555743A (fr)
UA (1) UA91203C2 (fr)
WO (1) WO2006059009A1 (fr)
ZA (1) ZA200705079B (fr)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2851066A1 (fr) * 2013-09-23 2015-03-25 LTS LOHMANN Therapie-Systeme AG Fixation de formulations de vaccin sur des dispositifs d'immunisation épidermique par adjuvants huileux

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US478056A (en) * 1892-06-28 Trustees
ZA872532B (en) 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
DE3867924D1 (de) * 1987-06-23 1992-03-05 Eniricerche Spa Ein-phasen-praeparat, das ein perfluoriertes oel und ein oder mehrere oberflaechenaktive stoffe enthaelt, verwendbar als hilfsstoff fuer kosmetische und dermatologische mittel sowie fuer biomedizinische anwendungen.
ZA903756B (en) 1989-05-16 1991-02-27 Puetter Medice Chem Pharm Pharmaceutical preparation
US5688761A (en) * 1991-04-19 1997-11-18 Lds Technologies, Inc. Convertible microemulsion formulations
US5961970A (en) * 1993-10-29 1999-10-05 Pharmos Corporation Submicron emulsions as vaccine adjuvants
US5744137A (en) * 1995-02-06 1998-04-28 The United States Of America As Represented By The Secretary Of The Agriculture Oil emulsion vaccines prepared with animal, vegetable, and synthetic oils using a mixture of nonionic surfactants
JP4104186B2 (ja) * 1995-11-30 2008-06-18 財団法人化学及血清療法研究所 オイルアジュバントワクチンおよびその調製方法
TW410158B (en) * 1995-11-30 2000-11-01 Chemo Sero Therapeut Res Inst Oil adjuvant vaccine and method for preparing same
CN1252711A (zh) * 1997-04-18 2000-05-10 大正制药株式会社 微乳
EP1469009A2 (fr) * 1998-05-21 2004-10-20 Isis Parmaceuticals, Inc. Compositions et procédés pour la délivrance non parentérale d'oligonucléotides
US6919442B1 (en) * 1998-05-22 2005-07-19 The United States Of America As Represented By The Department Of Health And Human Services Nucleic acids comprising a post-transcriptional regulatory element (PRE) and their uses
CN1303272A (zh) 1998-05-27 2001-07-11 尤罗塞尔蒂克股份有限公司 施用于上呼吸道和/或耳部的消炎剂,特别是抗菌剂和/或促进伤口愈合活性剂的制剂
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
JP4642950B2 (ja) 1999-03-04 2011-03-02 株式会社資生堂 メーキャップ除去用化粧料
JP4570705B2 (ja) * 1999-03-04 2010-10-27 株式会社資生堂 メーキャップ除去用化粧料
EP1104767A1 (fr) 1999-11-30 2001-06-06 Stichting Dienst Landbouwkundig Onderzoek Dérivés de mono- et disaccharides contenant esters d'acides gras et esters de sulfate
ATE320792T1 (de) 2000-09-28 2006-04-15 Chiron Corp Mikropartikel zur verabreichung von heterologen nukleinsäure
ES2331058T3 (es) * 2001-02-28 2009-12-21 Intervet International Bv Emulsiones de agua en aceite inyectables.
CN1636015A (zh) 2001-06-29 2005-07-06 希龙公司 Hcv e1e2疫苗组合物
US20030119774A1 (en) * 2001-09-25 2003-06-26 Marianna Foldvari Compositions and methods for stimulating an immune response
PL1613346T3 (pl) * 2003-04-04 2013-03-29 Zoetis Services Llc Poddane mikrofluidyzacji emulsje typu olej w wodzie i kompozycje szczepionek
US20060292186A1 (en) * 2003-08-29 2006-12-28 Novagali Pharma Sa Self-nanoemulsifying oily formulation for the administration of poorly water-soluble drugs

Also Published As

Publication number Publication date
IL183518A (en) 2011-09-27
NZ555743A (en) 2009-06-26
BRPI0517124A (pt) 2008-09-30
MX2007006521A (es) 2007-11-08
US8158133B2 (en) 2012-04-17
EP1817053A1 (fr) 2007-08-15
EA200701201A1 (ru) 2007-10-26
NO20073333L (no) 2007-08-17
KR20070106988A (ko) 2007-11-06
WO2006059009A1 (fr) 2006-06-08
CA2589841A1 (fr) 2006-06-08
UA91203C2 (ru) 2010-07-12
CN101111262A (zh) 2008-01-23
AU2005311188A1 (en) 2006-06-08
JP2008521865A (ja) 2008-06-26
IL183518A0 (en) 2007-09-20
US20080026006A1 (en) 2008-01-31
AU2005311188B2 (en) 2011-07-07
FR2878746A1 (fr) 2006-06-09
ZA200705079B (en) 2008-08-27
JP4987725B2 (ja) 2012-07-25

Similar Documents

Publication Publication Date Title
IL187957A0 (en) Liquid pharmaceutical formulations of docetaxel
CL2009000380A1 (es) Compuestos derivados de heterociclos, moduladores de beta-amiloide; proceso de preparacion; composicion farmaceutica; y uso en el tratamiento de la enfermedad de alzheimer, angioplastia cerebral amiloide, demencia multiinfarto, sindrome de down, entre otras.
PH12014500053A1 (en) Proteasome inhibitors
FR14C0069I2 (fr) Composition pharmaceutique comprenant le lurasidone
CR8642A (es) Compuestos, composiciones farmaceuticas y metodos para su uso en el tratameinto de desordenes metabolicos
MA30236B1 (fr) Nouvelle composition pharmaceutique
BRPI0820665A2 (pt) compostos de peptidil nitrilas, processos para fabricação dos mesmos, composição farmacêutica, combinação e uso de ditos compostos
FR2881652B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesuage
FR2892937B1 (fr) Forme pharmaceutique orale microparticulaire anti-mesusage
DK1962873T3 (da) Farmaceutiske sammensætninger omfattende oxalat-reducerende bakterier
CL2007002207A1 (es) Compuestos derivados de sulfonilaminas; composicion farmaceutica; y uso de los compuestos en el tratamiento del glaucoma.
FR18C1032I2 (fr) Anticorps anti-fgf23 et composition pharmaceutique le comprenant
DK2216021T3 (da) Farmaceutisk sammensætning til behandling af overaktiv blære
EP2130825A4 (fr) Dérivés de thiomorpholine substitués en n en tant qu'inhibiteurs de la dipeptidyl peptidase iv et leurs utilisations pharmaceutiques
DK1868581T3 (da) Farmaceutiske sammensætninger med forbedrede opløsningsprofiler til dårligt opløselige lægemidler
BRPI0818267A2 (pt) Novos derivados de 1,3-dihidro-5-isobenzofuranocarbonitrila e composição farmacêutica dos mesmos para o tratamento de ejaculação precoce
DE602006007995D1 (de) Formulierungen von liponsäure und hyaluronsäurebeneichen
MA28603B1 (fr) Composition pharmaceutique antimycobacterienne
CL2013001164A1 (es) Composicion que contiene 2-metilpropanotioato de s-[2-([[1-(2-etilbutil)-ciclohexil]-carbonil]amino)fenilo] y croscarmelosa sodica; proceso de preparacion; tableta que la contiene; kit y uso en el tratamiento y prevencion de trastornos cardiovasculares.
DK1833462T3 (da) Farmaceutisk fremstillingsfremgangsmåde til varmesteriliserede glucocorticoidsuspensioner
PT2340872T (pt) Novas formulações farmacêuticas úteis no tratamento de insónia
FR2878746B1 (fr) Nouvelle composition pharmaceutique utilisable dans le domaine des vaccins
DK1617827T3 (da) Farmaceutisk sammensætning i form af en hydrogel til den transdermale administration af aktivstoffer
DK1798234T3 (da) Farmaceutisk sammensætning omfattende temozolomidester
FR2906722B3 (fr) Nouvelle composition pharmaceutique et cosmetique et ses applications dermatologiques dans les corrections des epitheliums deshydrates

Legal Events

Date Code Title Description
ST Notification of lapse

Effective date: 20130830